Edmond De Rothschild Holding S.A. Biomarin Pharmaceutical Inc Transaction History

Edmond De Rothschild Holding S.A.

$6.16 Billion
Q2 2025

A detailed history of Edmond De Rothschild Holding S.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 649,420 shares of BMRN stock, worth $36.1 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

649,420

Previous 563,530 15.24%

Holding current value

$36.1 Million

Previous $39.8 Million 10.39%

% of portfolio

0.58%

Previous 0.72%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$54.08 - $68.32 $4.64 Million - $5.87 Million	85,890 Added 15.24%	649,420 $35.7 Million
Q4 2024 Feb 12, 2025	BUY	$61.93 - $70.49 $9.31 Million - $10.6 Million	150,303 Added 36.37%	563,530 $37 Million
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $15.5 Million - $21 Million	224,000 Added 118.38%	413,227 $29 Million
Q1 2024 May 08, 2024	SELL	$83.81 - $99.0 $2.54 Million - $3 Million	-30,306 Reduced 13.8%	189,227 $16.5 Million
Q4 2023 Feb 12, 2024	BUY	$76.22 - $98.51 $762 - $985	10 Added 0.0%	219,533 $21.2 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $6.06 Million - $6.73 Million	71,217 Added 48.02%	219,523 $19.4 Million
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $5.07 Million - $5.87 Million	58,506 Added 65.15%	148,306 $12.9 Million
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $1.32 Million - $1.76 Million	15,000 Added 20.05%	89,800 $8.73 Million
Q4 2022 Feb 09, 2023	SELL	$80.93 - $108.63 $868,378 - $1.17 Million	-10,730 Reduced 12.55%	74,800 $7.74 Million
Q3 2022 Nov 09, 2022	BUY	$82.16 - $96.94 $2.37 Million - $2.79 Million	28,800 Added 50.77%	85,530 $7.25 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $3.96 Million - $4.81 Million	55,386 Added 4120.98%	56,730 $4.7 Million
Q1 2022 May 10, 2022	SELL	$74.28 - $92.69 $38,997 - $48,662	-525 Reduced 28.09%	1,344 $104,000
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $9,323 - $11,891	-130 Reduced 6.5%	1,869 $165,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $361,139 - $412,820	-4,830 Reduced 70.73%	1,999 $155,000
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $4,908 - $5,511	-65 Reduced 0.94%	6,829 $570,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $515,188 - $625,216	6,894 New	6,894 $521,000

Others Institutions Holding BMRN

# of Institutions

675

Shares Held

185M

Call Options Held

1.31M

Put Options Held

1.1M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Account

Edmond De Rothschild Holding S.A. Biomarin Pharmaceutical Inc Transaction History